While the researchers did not find evidence that people who lost more body weight had a larger reduction in cardiovascular risk, they did find that larger decreases in waist circumference (a more sensitive marker of visceral fat) accounted for roughly a third of the reduction in cardiac risk in the semaglutide group, still leaving most of the benefit unexplained by changes in body composition
These connections have fueled interest in whether intentional weight loss can improve outcomes
With EU-based inventory and tracked logistics, BioBoostX provides documented laboratory materials with transparent specifications and clear labeling
Ozempic Sulfur Burps, Gas, and Bloating: Why GLP-1 Medications Cause the Food-Stuck Feeling Joshua Silva, MD Jan 26 8 min read Updated: Feb 4 Medically authored by Joshua Silva, MD | Evidence-Based Weight Loss at Potere Health MD Many people taking GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) experience digestive symptoms including bloating, sulfur-smelling burps, excess gas, early satiety, or a heavy sensation that food feels stuck after meals
These medications do not reverse the surgery but work with the surgical anatomy to help patients reestablish a healthy, predictable eating rhythm
If you have had previous bariatric surgery A Physicians Take on the Oral vs Injection Weight Loss Drug Debate I have a lot of patients in Asheville, NC, on injection weight loss medications, and a few on the new oral options
